Edition:
United Kingdom

Profile: OncoTherapy Science Inc (4564.T)

4564.T on Tokyo Stock Exchange

123JPY
7:00am BST
Change (% chg)

¥-1 (-0.81%)
Prev Close
¥124
Open
¥123
Day's High
¥125
Day's Low
¥123
Volume
617,300
Avg. Vol
1,205,025
52-wk High
¥217
52-wk Low
¥108

OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with universities and other corporations. The Company provides its licenses to pharmaceutical manufacturers. The Company also involves in T Cell Receptor(TCR) analysis business.

Company Address

OncoTherapy Science Inc

6F, Kanagawa Science Park R&D Bl
3-2-1, Sakado, Takatsu-ku
KAWASAKI-SHI   KNG   213-0012
P: +8144.8208251
F: +8144.8208260

Company Web Links